News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Luciano Costa: JNJ-5322 is Likely The Greatest Innovation We Have Seen in a Few Years
Luciano Costa/LinkedIn
May 26, 2025, 08:09

Luciano Costa: JNJ-5322 is Likely The Greatest Innovation We Have Seen in a Few Years

Luciano J Costa, Professor at University of Alabama at Birmingham, shared a post on X:

“A lot in multiple myeloma at ASCO.

JNJ-5322 is likely the greatest innovation we have seen in a few years.

Potential to disrupt our approach to immunotherapy even before we figure out the current players. ⁦

Congratulations to the investigators.”

More posts featuring ASCO25.

ASCO25 cancer immunotherapy JnJ Innovative Medicine JNJ-5322 Luciano J Costa OncoDaily Oncology
Special Coverage
Blog
Jul 18, 2025, 01:13
Get to Know Honami Naora and Her Ovarian Cancer Research Team - MD Anderson Cancer Center
Blog
Jul 18, 2025, 01:00
Why Submit an Abstract at the ESMO Immuno-Oncology Congress 2025?
Blog
Jul 18, 2025, 00:39
Domitille de La Gorce: Greetings from Ghana
Career
Jul 18, 2025, 00:10
Ammira Al-Shabeeb: We're Hiring a Data Scientist/Bioinformatician
Blog
Jul 17, 2025, 23:43
Olubukola Ayodele: An Inner Conviction That Drove Me Here
Blog
Jul 17, 2025, 23:17
7th Cancer Genomics, Multiomics, and Computational Biology Cretonference Returns - EACR
Blog
Jul 17, 2025, 20:51
Applications are open for the Certificate of Competence in Breast Cancer - European School of Oncology
Career
Jul 17, 2025, 20:39
Sally Donaldson Started New Role As Senior Fellowships and Grants Manager at UICC
Insight
Jul 17, 2025, 20:26
Key Reason Some Cancer Patients Relapse After Receiving CAR-T Cell Therapy - Mayo Clinic
Blog
Jul 17, 2025, 19:54
Vahe Grigoryan: Our Abstract has been Accepted as a Poster Presentation at the ESMO 2025 Congress
Blog
Jul 17, 2025, 19:32
Amol Akhade: What You Think is the Best Way to Raise Critical Questions About a Published Trial?
Blog
Jul 17, 2025, 19:20
People with Lung Cancer are Excluded from Clinical Trials More Than Any Other Cancer Group